Journal of the National Cancer Institute, ‎0027-8874

Journal

Publications

  1. Published
  2. Published

    The effect of metformin vs placebo on sex hormones in Canadian cancer trials group MA.32

    Daniel Rea & 5 others, , , , & , Feb 2021, In: Journal of the National Cancer Institute. 113, 2, p. 192-198 7 p.

    Research output: Contribution to journalArticlepeer-review

  3. Published

    Systematic evaluation of Patient-Reported Outcome protocol content and reporting in cancer trials

    Derek Kyte, Ameeta Retzer, Khaled Ahmed, Tom Keeley, , , , , , , , , , , , , , Grace Turner & Melanie Calvert, Nov 2019, In: Journal of the National Cancer Institute. 111, 11, p. 1170-1178 9 p.

    Research output: Contribution to journalArticlepeer-review

  4. Published

    Speeding up the evaluation of new agents in cancer

    Nicholas James, , , & , 1 Sep 2008, In: Journal of the National Cancer Institute. 100, 17, p. 1204-1214 11 p.

    Research output: Contribution to journalEditorial

  5. Published
  6. Published

    Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial

    Emilio Porfiri & , 15 Oct 2008, In: Journal of the National Cancer Institute. 100, 20, p. 1454-63 10 p.

    Research output: Contribution to journalArticle

  7. Published

    Risk of soft-tissue sarcoma among 69 460 five-year survivors of childhood cancer in Europe

    Michael Hawkins & 21 others, , , , , , , , , , , , , , , , , , , , Raoul Reulen & , Jun 2018, In: Journal of the National Cancer Institute. 110, 6, p. 649–660

    Research output: Contribution to journalArticlepeer-review

  8. Published

    Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe

    Raoul Reulen & 20 others, , , , , , , , , , , , , , , , , , , & Michael Hawkins, Feb 2018, In: Journal of the National Cancer Institute. 110, 2

    Research output: Contribution to journalArticlepeer-review

  9. Published
  10. Published

    Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

    Jayne Wilson, , , , Josie Sandercock, , , , , , , Christopher Hyde & , 17 May 2006, In: Journal of the National Cancer Institute. 98, 10, p. 708-714 7 p.

    Research output: Contribution to journalArticlepeer-review

  11. Published

    Re: Selenium and Vitamin E: Interesting Biology and Dashed Hope

    Maurice Zeegers, 7 Oct 2009, In: Journal of the National Cancer Institute. 101, 19, p. 1363-1364 2 p.

    Research output: Contribution to journalArticle

  12. Published
  13. Published
  14. Published
  15. Published
  16. Published

    PMS2 mutations in childhood cancer

    Eamonn Maher, , , , , , & , 1 Jan 2006, In: Journal of the National Cancer Institute. 98, 5, p. 358-361 4 p.

    Research output: Contribution to journalArticle

  17. Published
  18. Published
  19. Published
  20. Published
  21. Published

    Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression

    Farida Latif, , , , , , & , 1 May 2001, In: Journal of the National Cancer Institute. 93, 9, p. 691-699 9 p.

    Research output: Contribution to journalArticle

  22. Published
  23. Published
  24. Published
  25. Published
  26. Published
  27. Published

    Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis

    Anthony Kong, , & , 7 Nov 2012, In: Journal of the National Cancer Institute. 104, 21, p. 1625-34 10 p.

    Research output: Contribution to journalArticlepeer-review

  28. Published